Jeffrey Simmons compensation by year
ELI LILLY Summary Compensation Table · the one fiscal year held| Component | FY2018 |
|---|---|
| Salary | $775,185 |
| Bonus | $0 |
| Stock awards | $2,530,654 |
| Option awards | $1,119,445 |
| Non-equity incentive | $907,450 |
| Pension and deferred compensation | $0 |
| All other | $46,511 |
| Total | $5,379,245 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ELI LILLY & Co DEF 14A filed March 22, 2019, accession 0000059478-19-000146, and prior-year filings. Open the filing on EDGAR.
How this page was built: the ELI LILLY & Co filed document, accession 0000059478-19-000146. Every figure is read from that document and cited to the page and table it appears in. Filed March 22, 2019.
ELI LILLY’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| David Ricks | Chairman, President, and Chief Executive Officer | $17,230,337 |
| Michael Harrington | Senior Vice President and General Counsel | $5,440,320 |
| Jeffrey Simmons · this page | President, Chief Executive Officer and Director Elanco Animal Health, Inc. | $5,379,245 |
| Joshua Smiley | Senior Vice President and Chief Financial Officer | $5,245,343 |
| Daniel Skovronsky | Senior Vice President and Chief Scientific Officer | $5,145,898 |
| Enrique Conterno | Senior Vice President and President, Lilly Diabetes and President, Lilly USA | $4,999,806 |
The full ELI LILLY compensation record
free company briefThis page is one person within ELI LILLY's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the ELI LILLY proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ELI LILLY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.